Provided by Tiger Trade Technology Pte. Ltd.

Sanofi SA

44.36
-0.4600-1.03%
Post-market: 44.380.0199+0.04%18:42 EDT
Volume:2.35M
Turnover:104.31M
Market Cap:106.29B
PE:23.79
High:44.69
Open:44.59
Low:44.26
Close:44.82
52wk High:52.68
52wk Low:40.89
Shares:2.40B
Float Shares:2.16B
Volume Ratio:1.42
T/O Rate:0.11%
Dividend:2.39
Dividend Rate:5.39%
EPS(TTM):1.86
EPS(LYR):3.76
ROE:5.71%
ROA:5.09%
PB:1.32
PE(LYR):11.80

Loading ...

New CEO Upgrades Guidance Yet Shares Fall as Sanofi's Pipeline Drought Becomes a Key Weakness

Stock News
·
Jul 30

Sanofi's New CEO Might be Done with Major Portfolio Pruning

Dow Jones
·
Jul 30

Sanofi Might be Better Off Favoring Deals over Internal Drugs

Dow Jones
·
Jul 30

Sanofi Targets Dual RSV–HMPV Opportunity With Fresh Phase 1/2 Vaccine Study

TIPRANKS
·
Jul 30

Sanofi Pauses Key Bronchiectasis Trial, Raising Questions For SNY Investors

TIPRANKS
·
Jul 30

Movement Alert|Sanofi SA Rises 3.07% in Regular Trading, Pharma Sector Rallies Ahead of Q2 Earnings

Market Focus
·
Jul 28

Sanofi SA Expected to Post Earnings of $1.14 a Share - Earnings Preview

Reuters
·
Jul 28

Sanofi New CEO's Plans Take Spotlight

Dow Jones
·
Jul 28

Top Midday Gainers

MT Newswires Live
·
Jul 25

Sanofi Advances Real-World Asthma Study, Sharpening Its Long-Term Biologics Strategy

TIPRANKS
·
Jul 25

Sanofi Halts Development of Atopic Dermatitis Drug

MT Newswires Live
·
Jul 24

Scribe Therapeutics Prices Upsized IPO at $15 per Share

MT Newswires Live
·
Jul 24

Earning Preview: Sanofi SA this quarter’s revenue is expected to increase by 9.85%, and institutional views are bullish

Earnings Agent
·
Jul 24

Sanofi announces Executive Committee to support next strategic chapter

TIPRANKS
·
Jul 22

European Equities Traded in the US as American Depositary Receipts Track Lower in Monday Trading

MT Newswires Live
·
Jul 20

Sanofi Sues Pfizer, Moderna over COVID Shot Technology

Reuters
·
Jul 15

Movement Alert|Sanofi Falls 3.23% in Pre-Market Trading, Trading at $43.32

Market Focus
·
Jul 14

Movement Alert|Sanofi Declines 3.23% Overnight, Trading at $42.58

Market Focus
·
Jul 14

Analysts Conflicted on These Healthcare Names: Sanofi (SNY) and Johnson & Johnson (JNJ)

TIPRANKS
·
Jul 11

Sanofi Says US FDA Approves Subcutaneous Sarclisa for Multiple Myeloma

MT Newswires Live
·
Jul 10